2,4-dichloro-1-(dichloromethyl)benzene

We are 2,4-dichloro-1-(dichloromethyl)benzene CAS:134-25-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,4-dichloro-1-(dichloromethyl)benzene
CAS.NO:134-25-8
Synonyms:2,4-dichloro-1-(dichloromethyl)benzene
2,4-Dichloro benzal chloride
2,4-Dichlor-benzalchlorid
2,3-THIOPHENEDICARBOXYLATE
2,4-dichlorobenzyl dichloride
 
Physical and Chemical Properties:
Density 1.501 g/cm3
Boiling Point 273.9ºC at 760 mmHg
Molecular Formula C7H4Cl4
Molecular Weight 229.91900
Flash Point 123.4ºC
Vapour Pressure 0.00932mmHg at 25°C
Index of Refraction 1.575
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Diniconazole(CAS:76714-88-0).

2,4-dichloro-1-(dichloromethyl)benzene


Related News: The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.23787-80-6 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.5,6-dimethoxy-2,3-dihydroinden-1-one CAS:2107-69-9 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.8-bromooctyl acetate CAS:53596-81-9 The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.

Related Products
Product Name
2-methoxy-5-nitrobenzenediazonium View Details
Iminodiacetonitrile View Details
Ethyl 2-(3-bromo-4-isobutoxyphenyl)- 4-methyl-5-thiazolecarboxylate View Details
3-BAEPF manufacturer (2-methylpyridin-4-yl)boronic acid,hydrochloride manufacturer 3,4-dihydro-1H-naphthalen-2-one manufacturer VINYLTRIS(TERT-BUTYLPEROXY)SILANE manufacturer Bis(2-dimethylaminoethyl) ether manufacturer